REQUEST A DEMO
Total
USD $0.00
Search more companies

Cds - Viroplastic Cz S.R.O. (Czech Republic)

Main Activities: Plastics Product Manufacturing
Full name: Cds - Viroplastic Cz S.R.O. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Cds - Viroplastic Cz S.R.O. is based in Czech Republic, with the head office in Prague. It operates in the Plastics Product Manufacturing sector. Cds - Viroplastic Cz S.R.O. was incorporated on February 18, 2013. 25 - 49 (2023) employees currently work for Cds - Viroplastic Cz S.R.O.. There was a net sales revenue increase of 16.63% reported in Cds - Viroplastic Cz S.R.O.’s latest financial highlights for 2022. Its total assets decreased by 6.67% over the same period. In 2022, Cds - Viroplastic Cz S.R.O.’s net profit margin decreased by 1.43%.

Headquarters
Machova 838/18
Prague; The City of Prague; Postal Code: 12000

Contact Details: Purchase the Cds - Viroplastic Cz S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Cds - Viroplastic Cz S.R.O. report to view the information.
Outstanding Shares:
Purchase the Cds - Viroplastic Cz S.R.O. report to view the information.
Registered Capital:
Purchase the Cds - Viroplastic Cz S.R.O. report to view the information.
Incorporation Date:
February 18, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Cds - Viroplastic Cz S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
16.63%
Total operating revenue
15.55%
Operating profit (EBIT)
-21.99%
EBITDA
-10.11%
Net Profit (Loss) for the Period
-29.67%
Total assets
-6.67%
Total equity
3.89%
Operating Profit Margin (ROS)
-1.79%
Net Profit Margin
-1.43%
Return on Equity (ROE)
-1.79%
Debt to Equity Ratio
-8.54%
Quick Ratio
0.84%
Cash Ratio
0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?